UXS1 and metabolic dysfunction-associated steatohepatitis: We fed mice with CD-HFD for 4 weeks to establish NASH and then intravenously injected mice with AAV-shRNA-Uxs1 or scrambled control (AAV-shRNA-NC) while continuing CD-HFD for additional 8 weeks (Supplementary Fig. 9b).